Yonghe Medical Group Co., Ltd. (HKG:2279)
Hong Kong · Delayed Price · Currency is HKD 2.130
+0.180 (9.23%)
At close: Apr 24, 2026
Yonghe Medical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,808 | 1,804 | 1,777 | 1,413 | 2,169 | |
Revenue Growth (YoY) | 0.21% | 1.53% | 25.80% | -34.85% | 32.37% |
Cost of Revenue | 614.1 | 720.29 | 780.07 | 540.21 | 588.6 |
Gross Profit | 1,194 | 1,084 | 997.19 | 872.58 | 1,580 |
Selling, General & Admin | 1,043 | 1,188 | 1,419 | 1,024 | 1,320 |
Research & Development | 19.26 | 21.25 | 29.28 | 18.5 | 14.16 |
Other Operating Expenses | 7.59 | -3.09 | 6.68 | -8.66 | -4.92 |
Operating Expenses | 1,070 | 1,206 | 1,455 | 1,034 | 1,329 |
Operating Income | 124.17 | -121.63 | -457.47 | -161.46 | 250.49 |
Interest Expense | -23.03 | -41.22 | -54.16 | -51.23 | -51.95 |
Interest & Investment Income | 10.1 | 10.57 | 12.7 | 15.26 | 6.13 |
Currency Exchange Gain (Loss) | -0.24 | 0.05 | -12.01 | 88.12 | - |
Other Non Operating Income (Expenses) | - | - | 0.02 | -0.25 | 0.21 |
EBT Excluding Unusual Items | 111 | -152.23 | -510.92 | -109.55 | 204.88 |
Impairment of Goodwill | - | -10.33 | - | - | - |
Gain (Loss) on Sale of Assets | -8.26 | -51.78 | -52.35 | -2.04 | -1.13 |
Asset Writedown | -1.42 | -50.5 | -28.4 | - | - |
Other Unusual Items | 4.12 | 9.55 | 6.45 | 2.12 | 6.52 |
Pretax Income | 105.45 | -255.29 | -585.22 | -109.47 | 210.28 |
Income Tax Expense | 31.89 | -28.72 | -38.54 | -23.61 | 90.09 |
Earnings From Continuing Operations | 73.56 | -226.57 | -546.68 | -85.86 | 120.19 |
Minority Interest in Earnings | 0.15 | 0.23 | 0.29 | - | - |
Net Income | 73.71 | -226.34 | -546.39 | -85.86 | 120.19 |
Preferred Dividends & Other Adjustments | - | - | - | -1.88 | 2.62 |
Net Income to Common | 73.71 | -226.34 | -546.39 | -83.98 | 117.57 |
Net Income Growth | - | - | - | - | -26.41% |
Shares Outstanding (Basic) | 500 | 501 | 506 | 513 | 401 |
Shares Outstanding (Diluted) | 500 | 501 | 506 | 513 | 430 |
Shares Change (YoY) | -0.13% | -1.01% | -1.36% | 19.23% | 2.65% |
EPS (Basic) | 0.15 | -0.45 | -1.08 | -0.16 | 0.29 |
EPS (Diluted) | 0.15 | -0.45 | -1.08 | -0.16 | 0.28 |
EPS Growth | - | - | - | - | -28.32% |
Free Cash Flow | 477.76 | 182.95 | -176.35 | -349.14 | 255.65 |
Free Cash Flow Per Share | 0.95 | 0.36 | -0.35 | -0.68 | 0.59 |
Dividend Per Share | 0.076 | - | - | - | 0.076 |
Gross Margin | 66.04% | 60.08% | 56.11% | 61.76% | 72.86% |
Operating Margin | 6.87% | -6.74% | -25.74% | -11.43% | 11.55% |
Profit Margin | 4.08% | -12.54% | -30.74% | -5.94% | 5.42% |
Free Cash Flow Margin | 26.42% | 10.14% | -9.92% | -24.71% | 11.79% |
EBITDA | 236.89 | 36.16 | -292.24 | -54.42 | 342.56 |
EBITDA Margin | 13.10% | 2.00% | -16.44% | -3.85% | 15.80% |
D&A For EBITDA | 112.72 | 157.79 | 165.23 | 107.04 | 92.07 |
EBIT | 124.17 | -121.63 | -457.47 | -161.46 | 250.49 |
EBIT Margin | 6.87% | -6.74% | -25.74% | -11.43% | 11.55% |
Effective Tax Rate | 30.24% | - | - | - | 42.84% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.